50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader continues Gulf tour with stops in UAE, Qatar
US spy satellite launched into orbit from California
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader continues Gulf tour with stops in UAE, Qatar
US spy satellite launched into orbit from California
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader continues Gulf tour with stops in UAE, Qatar
US spy satellite launched into orbit from California
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader seeks energy deals, alliances on Gulf trip
Saudi Arabia's triumphant week reclaims the West's embrace
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Poverty, inflation, fear: Egypt's economy pushed to brink
Poverty and inflation: Egypt's economy hit by global turmoil
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
German leader continues Gulf tour with stops in UAE, Qatar
US spy satellite launched into orbit from California
NASDAQ:SGRY

Surgery Partners - SGRY Stock Forecast, Price & News

$24.80
-0.11 (-0.44%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$24.01
$24.87
50-Day Range
$24.80
$39.38
52-Week Range
$24.01
$63.87
Volume
510,762 shs
Average Volume
544,505 shs
Market Capitalization
$2.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.44

Surgery Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
131.6% Upside
$57.44 Price Target
Short Interest
Bearish
12.66% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.17mentions of Surgery Partners in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$15,704 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.01) to $0.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

Medical Sector

898th out of 1,075 stocks

General Medical & Surgical Hospitals Industry

5th out of 5 stocks

SGRY stock logo

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

Surgery Partners (NASDAQ:SGRY) Hits New 12-Month Low at $24.01
Surgery Partners (NASDAQ:SGRY) Trading Down 6.9%
SGRY Surgery Partners, Inc.
Recap: Surgery Partners Q2 Earnings
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Company Calendar

Last Earnings
8/02/2022
Today
9/25/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
General medical & surgical hospitals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGRY
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$57.44
High Stock Price Forecast
$73.00
Low Stock Price Forecast
$36.00
Forecasted Upside/Downside
+131.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-70,900,000.00
Pretax Margin
5.37%

Debt

Sales & Book Value

Annual Sales
$2.23 billion
Cash Flow
$1.02 per share
Book Value
$22.05 per share

Miscellaneous

Free Float
86,967,000
Market Cap
$2.23 billion
Optionable
Optionable
Beta
2.90

Key Executives

  • Mr. Wayne Scott DeVeydtMr. Wayne Scott DeVeydt (Age 52)
    Exec. Chairman
    Comp: $500k
  • Mr. J. Eric Evans (Age 45)
    CEO & Director
    Comp: $1.81M
  • Ms. Jennifer B. BaldockMs. Jennifer B. Baldock (Age 51)
    Exec. VP and Chief Admin. & Devel. Officer
    Comp: $888.1k
  • Mr. Anthony W. TaparoMr. Anthony W. Taparo (Age 56)
    Chief Growth Officer
    Comp: $751.84k
  • Mr. Bradley R. Owens (Age 52)
    Pres of National Group
    Comp: $788.72k
  • Mr. David T. DohertyMr. David T. Doherty (Age 50)
    Exec. VP & CFO
  • Mr. Varun Gadhok
    Sr. VP & Chief Information Officer
  • Ms. Roxanne Womack
    Sr. VP & Chief Compliance Officer
  • Ms. Laura L. BrocklehurstMs. Laura L. Brocklehurst (Age 52)
    Sr. VP & Chief HR Officer
  • Mr. George M. GoodwinMr. George M. Goodwin (Age 61)
    Pres of ASC Group













SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price forecast for 2022?

6 Wall Street research analysts have issued twelve-month target prices for Surgery Partners' stock. Their SGRY share price forecasts range from $36.00 to $73.00. On average, they anticipate the company's stock price to reach $57.44 in the next year. This suggests a possible upside of 131.6% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2022?

Surgery Partners' stock was trading at $53.41 at the beginning of 2022. Since then, SGRY shares have decreased by 53.6% and is now trading at $24.80.
View the best growth stocks for 2022 here
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our SGRY earnings forecast
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings data on Tuesday, August, 2nd. The company reported ($0.08) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.08). The business earned $615.40 million during the quarter, compared to analysts' expectations of $624.64 million. Surgery Partners had a negative net margin of 1.23% and a negative trailing twelve-month return on equity of 0.61%.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.50 billion-$2.60 billion, compared to the consensus revenue estimate of $2.56 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (14.99%), Clearbridge Investments LLC (4.83%), Price T Rowe Associates Inc. MD (2.43%), Victory Capital Management Inc. (1.18%), Point72 Asset Management L.P. (1.10%) and State Street Corp (0.86%). Insiders that own company stock include Anthony Taparo, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $24.80.

How much money does Surgery Partners make?

Surgery Partners (NASDAQ:SGRY) has a market capitalization of $2.23 billion and generates $2.23 billion in revenue each year. The company earns $-70,900,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis.

How many employees does Surgery Partners have?

The company employs 10,900 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.